Table of Contents
ISRN Surgery
Volume 2012, Article ID 389385, 5 pages
http://dx.doi.org/10.5402/2012/389385
Clinical Study

Factors Related to Long-Term Survival in Patients Affected by Well-Differentiated Endocrine Tumors of the Pancreas

1Department of Surgery, S.Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy
2Department of Internal Medicine, S.Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy

Received 10 April 2012; Accepted 15 May 2012

Academic Editors: S. Germanos, K.-E. Kahnberg, and A. Petroianu

Copyright © 2012 Riccardo Casadei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Y. Bilimoria, J. S. Tomlinson, R. P. Merkow et al., “Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients,” Journal of Gastrointestinal Surgery, vol. 11, no. 11, pp. 1460–1469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Solcia, G. Kloppel, and L. Sobin, Histological Typing of Endocrine Tumours, World Health Organization International Histological classification of Tumours, Springer, Berlin, Germany, 2nd edition, 2000.
  3. J. Y. Scoazec and A. Couvelard, “The new WHO classification of digestive neuroendocrine tumors,” Annales de Pathologie, vol. 31, no. 2, pp. 88–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Rindi, G. Klöppel, H. Alhman et al., “TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system,” Virchows Archiv, vol. 449, no. 4, pp. 395–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Scarpa, W. Mantovani, P. Capelli et al., “Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients,” Modern Pathology, vol. 23, no. 6, pp. 824–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tomassetti, D. Campana, L. Piscitelli et al., “Endocrine pancreatic tumors: factors correlated with survival,” Annals of Oncology, vol. 16, no. 11, pp. 1806–1810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Fischer, J. Kleeff, I. Esposito et al., “Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas,” British Journal of Surgery, vol. 95, no. 5, pp. 627–635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Casadei, C. Ricci, R. Pezzilli et al., “Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series,” World Journal of Surgery, vol. 33, no. 11, pp. 2458–2463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Casadei, C. Ricci, D. Rega et al., “Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience,” Pancreas, vol. 39, no. 6, pp. 825–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Franko, W. Feng, L. Yip, E. Genovese, and A. J. Moser, “Non-functional neuroendocrine carcinoma of the pancreas: Incidence, tumor biology, and outcomes in 2,158 patients,” Journal of Gastrointestinal Surgery, vol. 14, no. 3, pp. 541–548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Casadei, C. Ricci, R. Pezzilli et al., “Are there prognostic factors related to recurrence in pancreatic endocrine tumors?” Pancreatology, vol. 10, no. 1, pp. 33–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Y. Bilimoria, M. S. Talamonti, J. S. Tomlinson et al., “Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients,” Annals of surgery, vol. 247, no. 3, pp. 490–500, 2008. View at Google Scholar · View at Scopus